Novel Technetium SPECT Imaging Matches Gallium PET for Prostate Cancer Therapy Selection
A prospective head-to-head clinical trial shows that technetium-99m SPECT/CT provides physiological biodistribution and treatment phenotyping comparable to gallium-68 PET/CT in ...




![SPECT/CT tracer [123I]I-PARPi mirrors PARP immunohistochemistry across cancers](https://scienmag.com/wp-content/uploads/2026/11/stackrss-featured-1538-350x250.jpg)





